Secondary acute lymphoblastic leukemia (sALL) following acute myeloid
leukemia (AML) is a rare event; only eight cases have been reported. W
e report a patient with acute promyelocytic leukemia (APL), in hematol
ogical and molecular remission who developed T-ALL three years after t
he diagnosis of APL. The morphological, cytochemical, phenotypical and
molecular features of this T-ALL were different from those of the pre
vious APL. The absence of t(15;17), negative PML/RAR alpha at reverse
transcription polymerase chain reaction (RT-PCR) analysis and presence
of TcR delta support the hypothesis that the T-ALL in this sALL case
originated from a different clone from that of the APL cells. (C)1998,
Ferrata Storti Foundation.